Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
0.765
+0.026 (3.46%)
At close: Apr 28, 2026, 4:00 PM EDT
0.780
+0.015 (1.99%)
After-hours: Apr 28, 2026, 4:36 PM EDT
Talphera Revenue
In the year 2025, Talphera had annual revenue of $28.00K.
Revenue (ttm)
$28.00K
Revenue Growth
n/a
P/S Ratio
1,380.03
Revenue / Employee
$2,333
Employees
12
Market Cap
38.27M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InterCure | 72.16M |
| Rockwell Medical | 69.26M |
| Aytu BioPharma | 62.64M |
| Cumberland Pharmaceuticals | 44.52M |
| BGM Group | 25.10M |
| Zhengye Biotechnology Holding | 21.46M |
| China Pharma Holdings | 4.14M |
| TherapeuticsMD | 3.02M |
TLPH News
- 4 weeks ago - Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 - PRNewsWire
- 5 weeks ago - Talphera Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 5 weeks ago - Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026 - PRNewsWire
- 2 months ago - Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial - PRNewsWire
- 5 months ago - Talphera Earnings Call Transcript: Q3 2025 - Transcripts
- 5 months ago - Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 6 months ago - Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025 - PRNewsWire